Aiming to move pathology into the molecular age, HistoRx Inc. will use its tissue-analysis algorithms, termed AQUA, to automate quantitative analysis of proteins in tissue samples for drug discovery and development. Eventually, HistoRx wants to use its reagents and in situ diagnostic instrumentation and software to replace the clinical pathologist's eye for biomarker analysis.
25 Science Park at Yale
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
